首页> 外文期刊>Journal of Sol-Gel Science and Technology >Preparation of 0.7SiO(2)center dot 0.3CaO/PCL hybrid layers via sol-gel dip coating for the surface modification of titanium implants: characterization, bioactivity and biocompatibility evaluation
【24h】

Preparation of 0.7SiO(2)center dot 0.3CaO/PCL hybrid layers via sol-gel dip coating for the surface modification of titanium implants: characterization, bioactivity and biocompatibility evaluation

机译:通过溶胶-凝胶浸涂制备用于钛植入物表面改性的0.7SiO(2)中心点0.3CaO / PCL杂化层:表征,生物活性和生物相容性评估

获取原文
获取原文并翻译 | 示例
           

摘要

When reactive coatings are applied to medical implants by means of the sol-gel dip-coating technique, the biological properties of the implant surface can be modified to simulate the properties of the surrounding tissues in such a way to provide a firm fixation of the implant. The aim of this study has been to modify the surface of titanium grade 4 (a material generally used in dental application) by dip coating with sol-gel synthesized organic/inorganic hybrid materials in order to improve their osseointegration ability. Different hybrids have been obtained, consisting of an inorganic 0.7SiO(2)center dot 0.3CaO-based matrix in which a biodegradable polymer, poly-epsilon-caprolactone (PCL), has been incorporated in different percentages. These materials, still in the sol phase, have been used to coat the titanium substrates by means of the dip-coating technique. Fourier transform infrared spectroscopy allowed the characterization of the materials and their classification as Class I hybrids, whereas a microstructural analysis of the obtained coatings, performed using scanning electron microscopy (SEM), detected that the PCL content affects film morphology. The potential applications of these coatings in the biomedical field have been evaluated by bioactivity and biocompatibility tests. SEM-EDS analysis of the coated titanium surfaces showed that the hydroxylapatite deposition occurs after 21 days of immersion in a simulated body fluid, an index of in vivo bone-bonding capability. Moreover, a WST-8 assay has shown that the vitality of fibroblast cells (3T3) seeded on the titanium specimens is higher when the coatings are applied and that the biocompatibility depends on PCL amount.
机译:当通过溶胶-凝胶浸涂技术将反应性涂料应用于医疗植入物时,可以修改植入物表面的生物学特性,以模拟周围组织的特性,从而为植入物提供牢固的固定。这项研究的目的是通过用溶胶-凝胶合成的有机/无机杂化材料浸涂来修饰4级钛(通常用于牙科应用的材料)的表面,以提高其骨整合能力。已获得不同的杂物,由基于0.7SiO(2)中心点0.3CaO的无机基体组成,其中以不同百分比掺入了可生物降解的聚合物聚ε-己内酯(PCL)。这些仍处于溶胶相的材料已经通过浸涂技术用于涂覆钛基底。傅里叶变换红外光谱法可以表征材料并将其分类为I类杂化物,而使用扫描电子显微镜(SEM)对获得的涂层进行显微结构分析,则检测到PCL含量会影响膜的形态。这些涂层在生物医学领域的潜在应用已经通过生物活性和生物相容性测试进行了评估。涂覆钛表面的SEM-EDS分析表明,羟基磷灰石沉积在浸入模拟体液中21天后发生,这是体内骨结合能力的指标。此外,WST-8分析表明,当施加涂层时,接种在钛样品上的成纤维细胞(3T3)的活力更高,并且生物相容性取决于PCL量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号